These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 23319035)

  • 81. Prediction of sustained virological response to combination therapy with pegylated interferon alfa and ribavirin in patients with genotype 3 chronic hepatitis C.
    Tohra SK; Taneja S; Ghosh S; Sharma BK; Duseja A; Dhiman RK; Das A; Chawla YK
    Dig Dis Sci; 2011 Aug; 56(8):2449-55. PubMed ID: 21706207
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Hepatitis C virus genetic diversity by geographic region within genotype 1-6 subtypes among patients treated with glecaprevir and pibrentasvir.
    Schnell G; Krishnan P; Tripathi R; Beyer J; Reisch T; Irvin M; Dekhtyar T; Lu L; Ng TI; Xie W; Pilot-Matias T; Collins C
    PLoS One; 2018; 13(10):e0205186. PubMed ID: 30286205
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Hepatitis C virus genotypes in the United States: epidemiology, pathogenicity, and response to interferon therapy. Collaborative Study Group.
    Zein NN; Rakela J; Krawitt EL; Reddy KR; Tominaga T; Persing DH
    Ann Intern Med; 1996 Oct; 125(8):634-9. PubMed ID: 8849147
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Treatment of chronic hepatitis C with peginterferon alfa-2b, plus ribavirin in end stage renal disease patients treated by hemodialysis: single Saudi center experience.
    Alsaran K; Sabry A; Molhem A
    Ren Fail; 2013; 35(10):1305-9. PubMed ID: 24059964
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Excellent superiority and specificity of COBAS TaqMan HCV assay in an early viral kinetic change during pegylated interferon alpha-2b plus ribavirin treatment.
    Ogawa E; Furusyo N; Toyoda K; Taniai H; Otaguro S; Kainuma M; Murata M; Sawayama Y; Hayashi J
    BMC Gastroenterol; 2010 Apr; 10():38. PubMed ID: 20398383
    [TBL] [Abstract][Full Text] [Related]  

  • 86. The pattern of pegylated interferon-alpha2b and ribavirin treatment failure in cirrhotic patients depends on hepatitis C virus genotype.
    Aghemo A; Rumi MG; Monico S; Prati GM; D'Ambrosio R; Donato MF; Colombo M
    Antivir Ther; 2009; 14(4):577-84. PubMed ID: 19578243
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Early anemia and rapid virological response improve the predictive efficiency of IL28B-genotype for treatment outcome to antiviral combination therapy in patients infected with chronic HCV genotype 1.
    Amanzada A; Schneider S; Moriconi F; Lindhorst A; Suermann T; van Thiel DH; Mihm S; Ramadori G
    J Med Virol; 2012 Aug; 84(8):1208-16. PubMed ID: 22711348
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Diversity of genotype and mode of spread of Hepatitis C virus in Northern India.
    Rehan HS; Manak S; Yadav M; ; Chopra D; Wardhan N
    Saudi J Gastroenterol; 2011; 17(4):241-4. PubMed ID: 21727729
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Characterization of hepatitis C virus genotypes by direct sequencing of HCV 5'UTR region of isolates from Saudi Arabia.
    Shier MK; El-Wetidy MS; Ali HH; Al-Qattan MM
    PLoS One; 2014; 9(8):e103160. PubMed ID: 25099694
    [TBL] [Abstract][Full Text] [Related]  

  • 90. HCV genotypes among 1013 Saudi nationals: a multicenter study.
    Al Traif I; Al Balwi MA; Abdulkarim I; Handoo FA; Alqhamdi HS; Alotaibi M; Aljumah A; Al Ashqar HI; Bzeizi K; Al Quaiz M; Alalwan A; Al Hamoudi W; Sanai F; Abdo A
    Ann Saudi Med; 2013; 33(1):10-2. PubMed ID: 23458933
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Distribution of hepatitis C virus (HCV) genotypes in a Saudi Arabian hospital during the 2015-2020 period.
    Almosa FAM; Alnasser AHA; Al-Tawfiq JA
    Infez Med; 2021; 29(3):450-455. PubMed ID: 35146350
    [TBL] [Abstract][Full Text] [Related]  

  • 92. SASLT practice guidelines for the management of hepatitis C virus infection: summary of recommendations.
    Alghamdi AS; Sanai FM; Ismail M; Alghamdi H; Alswat K; Alqutub A; Altraif I; Shah H; Alfaleh FZ
    Saudi J Gastroenterol; 2012; 18(5):293-8. PubMed ID: 23006455
    [No Abstract]   [Full Text] [Related]  

  • 93. A Healthcare-Associated Outbreak of HCV Genotype 2a at a Clinic in Seoul.
    Choi S; Lee H; Lee H; Chung YS
    Osong Public Health Res Perspect; 2021 Feb; 12(1):3-12. PubMed ID: 33659149
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Hepatitis: New route of HCV transmission.
    Greenhill C
    Nat Rev Gastroenterol Hepatol; 2013 Sep; 10(9):504. PubMed ID: 23917698
    [No Abstract]   [Full Text] [Related]  

  • 95. Prevailing genotypes of hepatitis C virus in Saudi Arabia: a systematic analysis of evidence.
    Abozaid SM; Shoukri M; Al-Qahtani A; Al-Ahdal MN
    Ann Saudi Med; 2013; 33(1):1-5. PubMed ID: 23458931
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Hepatitis C genotype 4: genotypic diversity, epidemiological profile, and clinical relevance of subtypes in Saudi Arabia.
    Al Ashgar HI; Khan MQ; Al-Ahdal M; Al Thawadi S; Helmy AS; Al Qahtani A; Sanai FM
    Saudi J Gastroenterol; 2013; 19(1):28-33. PubMed ID: 23319035
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Epidemiology of viral hepatitis in Saudi Arabia: are we off the hook?
    Abdo AA; Sanai FM; Al-Faleh FZ
    Saudi J Gastroenterol; 2012; 18(6):349-57. PubMed ID: 23150019
    [TBL] [Abstract][Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.